Revance Therapeutics, Inc. today announced new hire grants totaling an aggregate of 222,452 inducement restricted stock units ("RSUs") to 29 employees. The RSUs vest over four years, with 25% of the underlying shares vesting on each of the four...
Related Keywords
China , Tennessee , United States , , Linkedin , Nasdaq , Viatris Inc , Revance Therapeutics Inc , Compensation Committee Of Revance Board Directors , Compensation Committee , Shanghai Fosun Pharmaceutical , Revance Therapeutics , Resilient Hyaluronic Acid ,
comparemela.com © 2020. All Rights Reserved.